Jason L. Rowand

541 total citations
6 papers, 369 citations indexed

About

Jason L. Rowand is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, Jason L. Rowand has authored 6 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Neurology. Recurrent topics in Jason L. Rowand's work include Growth Hormone and Insulin-like Growth Factors (4 papers), Neuroblastoma Research and Treatments (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Jason L. Rowand is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (4 papers), Neuroblastoma Research and Treatments (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Jason L. Rowand collaborates with scholars based in United States and Netherlands. Jason L. Rowand's co-authors include Chandra Rao, Leon W.M.M. Terstappen, Grace Martin, Michael S. Pierce, Mark C. Connelly, Gerald V. Doyle, Michael Craig Miller, Peter Sabbatini, Arthur Groy and Charity Atkins and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Jason L. Rowand

6 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason L. Rowand United States	5	251	125	83	80	62	6	369
M. Koukourakis Greece	12	284 1.1×	227 1.8×	96 1.2×	125 1.6×	125 2.0×	28	563
C. Massard France	11	141 0.6×	87 0.7×	42 0.5×	130 1.6×	55 0.9×	40	325
A. Barnadas Spain	10	179 0.7×	244 2.0×	84 1.0×	88 1.1×	83 1.3×	27	419
Ettie Piura Israel	9	202 0.8×	181 1.4×	50 0.6×	98 1.2×	61 1.0×	13	383
Emily Wearne United States	6	159 0.6×	164 1.3×	34 0.4×	105 1.3×	53 0.9×	6	335
Mar Abad Spain	11	221 0.9×	172 1.4×	67 0.8×	121 1.5×	57 0.9×	25	483
Gianmarco Motta Italy	9	194 0.8×	127 1.0×	16 0.2×	85 1.1×	80 1.3×	18	395
Javier Pozas Spain	12	137 0.5×	190 1.5×	18 0.2×	113 1.4×	52 0.8×	24	375
Sumiko Okubo Japan	10	116 0.5×	165 1.3×	24 0.3×	68 0.8×	40 0.6×	25	296
Dongweon Song United States	9	219 0.9×	157 1.3×	30 0.4×	79 1.0×	91 1.5×	11	414

Countries citing papers authored by Jason L. Rowand

Since Specialization

Citations

This map shows the geographic impact of Jason L. Rowand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason L. Rowand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason L. Rowand more than expected).

Fields of papers citing papers by Jason L. Rowand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason L. Rowand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason L. Rowand. The network helps show where Jason L. Rowand may publish in the future.

Co-authorship network of co-authors of Jason L. Rowand

This figure shows the co-authorship network connecting the top 25 collaborators of Jason L. Rowand. A scholar is included among the top collaborators of Jason L. Rowand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason L. Rowand. Jason L. Rowand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Yang, Xiaoyu, Wei Xu, Sabrina A. Benchaar, et al.. (2013). Developability studies before initiation of process development. mAbs. 5(5). 787–794. 90 indexed citations

2.

Sabbatini, Peter, Jason L. Rowand, Arthur Groy, et al.. (2009). Antitumor Activity of GSK1904529A, a Small-molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase. Clinical Cancer Research. 15(9). 3058–3067. 62 indexed citations

3.

Sabbatini, Peter, Susan Korenchuk, Jason L. Rowand, et al.. (2009). GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers. Molecular Cancer Therapeutics. 8(10). 2811–2820. 86 indexed citations

4.

Rabindran, Sridhar K., Peter Sabbatini, Susan Korenchuk, et al.. (2009). Abstract #1740: Characterization of GSK1838705A, a small molecule inhibitor of the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase that delays growth of IGF-1R-dependent tumors and causes regression of ALK-dependent tumors in vivo. Cancer Research. 69. 1740–1740. 2 indexed citations

5.

Chamberlain, Stanley D., Joseph W. Wilson, Felix Deanda, et al.. (2008). Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 19(2). 469–473. 27 indexed citations

6.

Rowand, Jason L., Grace Martin, Gerald V. Doyle, et al.. (2007). Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry Part A. 71A(2). 105–113. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact